Health Economics and Outcomes Research (HEOR) as a tool for improving operational performance and competitive advantage
ESiOR Ltd provides companies, service providers and other entities operating in social care and healthcare with expert solutions, services, tools and consulting to aid decision making, management and marketing. Our expert services provide the means to identify, demonstrate, communicate and improve the competitiveness of products, services, processes and networks.
Benefit from our competence
ESiOR has considerable expertise and extensive experience in the key methods, solutions and approaches that enable knowledge management and competitive differentiation.
Our areas of expertize
- social and health economics
- outcomes research
- economic evaluation
- health technology assessments (HTA)
- cost-effectiveness analyses
- budget impact tools
- mathematical modelling
- goal setting
- data management
The full scope of our services varies from consulting to turnkey solutions encompassing design, analysis, model development, reporting, publication and communication.
We specialize in:
- commissioned research
- registry studies
- systematic literature reviews and meta-analysis
- health economic evaluations
- modelling and model development
- localizations and country adaptations
for global cost-effectiveness models.
Together with our long-term partner Farenta, we offer the most comprehensive range of market access services in Finland in terms of price and reimbursement applications, label extensions and other regulatory affairs.
From data to competitive advantage
The characteristics of products, services, programmes and networks can be made to stand out and they can be differentiated from their competitors with a unique selling point.
Sources for distinctive advantages:
- customer experience
- quality of life
- cost containment
- target attainment
- budget impact
- other outcomes and key performance indicators (KPI).
Differentiation is an essential part of having a competitive advantage.
It is time for celebration. ESiOR will participate in International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress in Vienna for the tenth time. ISPOR is a must for everyone interested in pharmacoeconomics and outcomes research. Let’s meet in the congress! Ongoing regional government reform and social welfare and healthcare (SOTE) reform will […]
Many patients with major depressive disorder (MDD) do not have adequate response to the first medical treatment or have adverse effects that lead to treatment discontinuation and change of medication. MDD causes major quality of life losses and it is among the leading causes of early retirement. As such, the assessment of cost-effectiveness of MDD […]